SCHEMBL7562831

SCHEMBL7562831

COc1nc(NC(=O)NS(=O)(=O)c2ccccc2C(=O)O)nc(C(F)(F)Cl)n1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 1/20 0.43
GAA P10253 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
CA12 O43570 3/20 0.37
CA9 Q16790 3/20 0.37
MAPK1 P28482 1/20 0.36
CDK1 P06493 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9749899 0.92 MAPT (0.46) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL7452390 0.88 MAPT (0.49) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL9202687 0.86 MAPT (0.46) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL9364251 0.84 MAPT (0.43) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL7563484 0.84 MAPT (0.42) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL66269 0.83 MAPT (0.46) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL30013512 0.83 MAPT (0.46) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL29396197 0.83 MAPT (0.46) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL7570836 0.83 MAPT (0.42) MAPTALDH1A1KDM4ENPC1GAA
SCHEMBL21462144 0.83 MAPT (0.46) MAPTALDH1A1KDM4ENPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413911-B1 REACTING A SULFONYL ISOCYANATE WITH A 2-AMINO-1,3,5-TRIAZINE OR 2-AMINOPYRIMIDINE, OR REACTING A SULFONAMIDE WITH A PHENYL CARBAMATE OR ISOCYANATE OF -1,3,5-TRIAZINE OR PYRIDINE BASF AKTIENGESELLSCHAFT (DE) 2002-07-02 US disclosed
US-20020049321-A1 Herbicidal sulfonylureas, their preparation and use MAYER HORST (DE) 2002-04-25 US disclosed
US-6320046-B1 A 2-AMINO-1,3,5-TRIAZINE AS CHEMICAL INTERMEDIATE; HIGH SELECTIVITY IN SENSITIVE CROPS BASF AKTIENGESELLSCHAFT (DE) 2001-11-20 US disclosed
US-6043196-A Herbicidal sulfonylureas, their preparation and use BASF AKTIENGESELLSCHAFT (DE) 2000-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049321-A1 Herbicidal sulfonylureas, their preparation and use SLC5A1, DDT, SLC5A2 MAPT 4842/4885ALDH1A1 1171/4885KDM4E 2158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.